Page last updated: 2024-08-16

technetium tc 99m sestamibi and Neoplasms, Skull

technetium tc 99m sestamibi has been researched along with Neoplasms, Skull in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blocklet, D; Schoutens, A; Seret, A1
Garcia, F; Montes, TC; Mota, JA; Muñoz, C; Pustilnik, N; Rivero, JI1
Aktolun, C; Berk, F; Demir, H1
Durmus Altun, G; Hacimahmutoglu, S; Omer Yigitbasi, N; Pekindil, G; Sarikaya, A; Uzal, C1

Other Studies

4 other study(ies) available for technetium tc 99m sestamibi and Neoplasms, Skull

ArticleYear
[Multifocal breast neoplasm with bone involvement].
    Revue medicale de Bruxelles, 1998, Volume: 19, Issue:6

    Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Femoral Neoplasms; Humans; Humerus; Lymphatic Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Skull Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi

1998
Uptake of Tc-99m sestamibi and Tc-99m MDP in anaplastic carcinoma of the thyroid (nondiagnostic CT and ultrasound scans).
    Clinical nuclear medicine, 1999, Volume: 24, Issue:5

    Topics: Carcinoma; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Skull; Skull Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography

1999
Detection of cold bone metastasis by Tc-99m MIBI imaging.
    Annals of nuclear medicine, 2001, Volume: 15, Issue:4

    Topics: Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Skull Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi

2001
Tc-99m MIBI filling pattern in a photopenic area of a Tc-99m MDP scan in a patient with metastatic bone involvement of breast carcinoma.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:5

    Topics: Aged; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Skull Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi

2002